Novavax 'confident' in scaling up to 100M vaccine doses by end of year: R&D chief
Maryland-based Novavax just began dosing for the Phase 1 clinical trial in Australia.
Novavax 'confident' in scaling up to 100M vaccine doses by end of year: R&D chief
Novavax 'confident' in scaling up to 100M vaccine doses by end of year: R&D chief
Maryland-based Novavax just began dosing for the Phase 1 clinical trial in Australia.
0 comments: